Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Apr, 2014 | Pages:
44 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Sunovion Pharmaceuticals Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Sunovion Pharmaceuticals Inc. - Product Pipeline Review - 2014', provides an overview of the Sunovion Pharmaceuticals Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Sunovion Pharmaceuticals Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Sunovion Pharmaceuticals Inc. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Sunovion Pharmaceuticals Inc.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Sunovion Pharmaceuticals Inc.'s pipeline products Reasons to buy - Evaluate Sunovion Pharmaceuticals Inc.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Sunovion Pharmaceuticals Inc. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Sunovion Pharmaceuticals Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Sunovion Pharmaceuticals Inc. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Sunovion Pharmaceuticals Inc. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Sunovion Pharmaceuticals Inc. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Sunovion Pharmaceuticals Inc. Snapshot 5 Sunovion Pharmaceuticals Inc. Overview 5 Key Information 5 Key Facts 5 Sunovion Pharmaceuticals Inc. - Research and Development Overview 6 Key Therapeutic Areas 6 Sunovion Pharmaceuticals Inc. - Pipeline Review 9 Pipeline Products by Stage of Development 9 Pipeline Products - Monotherapy 10 Pipeline Products - Partnered Products 11 Partnered Products/Combination Treatment Modalities 12 Sunovion Pharmaceuticals Inc. - Pipeline Products Glance 13 Sunovion Pharmaceuticals Inc. - Late Stage Pipeline Products 13 Pre-Registration Products/Combination Treatment Modalities 13 Phase III Products/Combination Treatment Modalities 14 Sunovion Pharmaceuticals Inc. - Clinical Stage Pipeline Products 15 Phase II Products/Combination Treatment Modalities 15 Phase I Products/Combination Treatment Modalities 16 Sunovion Pharmaceuticals Inc. - Early Stage Pipeline Products 17 Preclinical Products/Combination Treatment Modalities 17 Discovery Products/Combination Treatment Modalities 18 Sunovion Pharmaceuticals Inc. - Drug Profiles 19 eslicarbazepine acetate 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 glycopyrrolate 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 DSP-1053 24 Product Description 24 Mechanism of Action 24 R&D Progress 24 SEP-363856 25 Product Description 25 Mechanism of Action 25 R&D Progress 25 Drugs for Central Nervous System Disorders 26 Product Description 26 Mechanism of Action 26 R&D Progress 26 SUN 27 Product Description 27 Mechanism of Action 27 R&D Progress 27 EP-103 28 Product Description 28 Mechanism of Action 28 R&D Progress 28 Sunovion Pharmaceuticals Inc. - Pipeline Analysis 29 Sunovion Pharmaceuticals Inc. - Pipeline Products by Target 29 Sunovion Pharmaceuticals Inc. - Pipeline Products by Route of Administration 31 Sunovion Pharmaceuticals Inc. - Pipeline Products by Molecule Type 32 Sunovion Pharmaceuticals Inc. - Pipeline Products by Mechanism of Action 33 Sunovion Pharmaceuticals Inc. - Recent Pipeline Updates 35 Sunovion Pharmaceuticals Inc. - Dormant Projects 40 Sunovion Pharmaceuticals Inc. - Discontinued Pipeline Products 41 Discontinued Pipeline Product Profiles 41 DSP-8658 41 SEP-228432 41 tecastemizole 41 Sunovion Pharmaceuticals Inc. - Locations And Subsidiaries 42 Head Office 42 Other Locations & Subsidiaries 42 Appendix 43 Methodology 43 Coverage 43 Secondary Research 43 Primary Research 43 Expert Panel Validation 43 Contact Us 44 Disclaimer 44
List of Tables Sunovion Pharmaceuticals Inc., Key Information 5 Sunovion Pharmaceuticals Inc., Key Facts 5 Sunovion Pharmaceuticals Inc. - Pipeline by Indication, 2014 8 Sunovion Pharmaceuticals Inc. - Pipeline by Stage of Development, 2014 9 Sunovion Pharmaceuticals Inc. - Monotherapy Products in Pipeline, 2014 10 Sunovion Pharmaceuticals Inc. - Partnered Products in Pipeline, 2014 11 Sunovion Pharmaceuticals Inc. - Partnered Products/ Combination Treatment Modalities, Select 12 Sunovion Pharmaceuticals Inc. - Pre-Registration, 2014 13 Sunovion Pharmaceuticals Inc. - Phase III, 2014 14 Sunovion Pharmaceuticals Inc. - Phase II, 2014 15 Sunovion Pharmaceuticals Inc. - Phase I, 2014 16 Sunovion Pharmaceuticals Inc. - Preclinical, 2014 17 Sunovion Pharmaceuticals Inc. - Discovery, 2014 18 Sunovion Pharmaceuticals Inc. - Pipeline by Target, 2014 30 Sunovion Pharmaceuticals Inc. - Pipeline by Route of Administration, 2014 31 Sunovion Pharmaceuticals Inc. - Pipeline by Molecule Type, 2014 32 Sunovion Pharmaceuticals Inc. - Pipeline Products by Mechanism of Action, 2014 34 Sunovion Pharmaceuticals Inc. - Recent Pipeline Updates, 2014 35 Sunovion Pharmaceuticals Inc. - Dormant Developmental Projects, 2014 40 Sunovion Pharmaceuticals Inc. - Discontinued Pipeline Products, 2014 41 Sunovion Pharmaceuticals Inc., Other Locations 42 Sunovion Pharmaceuticals Inc., Subsidiaries 42
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
